BIP.UN.TO 0.46TOU.TO -0.58CAE.TO 0.14ARK.TO 0SGD.V 0.46AEM.TO -5.75MEQ.TO 0.96TRI.TO 5.14
Daily Stock Opinions and Ratings
Stockchase Opinions

Duncan StewartAnorMed IncAOM.TOTOP PICKNov 12, 2004

Likes their product AMD-3100 which harvests bone marrow cells with remarkable effect prior to chemo therapy. Lots of cash. Has more upside and less risk than the average biotech.
Duncan StewartDuncan Stewart
Owned
Unlock Rating
$6.28

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

DON'T BUY

AnorMed Inc(AOM.TO)

Mar 06, 2002
When their cancer drug didn't meet expectations, their partner dropped out. Have a lot of cash, but there are better companies available.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$4.45

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

AnorMed Inc(AOM.TO)

Apr 17, 2001
One of the best 2/3 junior biotechs. Working on 3 products. Good partnerships.
Photo of Bruce CooperBruce CooperUnlock Rating
$17.65

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

AnorMed Inc(AOM.TO)

Jan 23, 2001
In phase 2 for aids, cancer drugs & phase 3 for a kidney failure drug. Big partners
Photo of Steven MisenerSteven MisenerUnlock Rating
$18.15

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

AnorMed Inc(AOM.TO)

Dec 08, 2000
Has partnerships with leading global pharmaceuticals. Products are now in WAIT stage.
Photo of Bruce CooperBruce CooperUnlock Rating
$22.00

Stock price when the opinion was issued

biotechnologypharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

CRH 0.16$111.41
XLE 0.375$54.435
SPCX 6.65$161.25
MNST 0.23$93.25
XLE 0.375$54.435

Today's Top Picks

BIP.UN.T… 0.46$51.86
TOU.TO -0.58$60.46
CAE.TO 0.14$35.44
ARK.TO 0$
SGD.V 0.46$15.93

Popular Articles

Latest Sell Signals

MRVL -28.94$278.92
ATZ.TO -3.05$159.51
CCA.TO 0.84$63.55
ABX.TO -2.13$54.71
PRL.TO -0.26$24.08

Most Recent Experts

Jim Lebenthal

Jim Lebenthal

Cerity Partners

Joe Terranova

Joe Terranova

Virtus Investment Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Stephanie Link, Chief investment strategist, Hightower

Stephanie Link, Chief investment strategist, Hightower

Hightower

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automatically